Daito Pharmaceutical Co (TSE:4577) Pretax Margin %: 6.43% (As of Nov. 2025) — 41% Below Median


TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
75 GF Score
Price 円1,241.00
GF Value 円1,277.77
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co Pretax Margin %?

Daito Pharmaceutical Co TSE:4577 +1.80% 75 Pretax Margin % is 6.43% as of Nov. 2025, which is 41% below its 10-year median of 10.96. GuruFocus rates TSE:4577 with a GF Score™ of 75/100 and a GF Value™ of 円1,277.77 (Fairly Valued). The stock has 3 warning signs investors should review. Among 954 Drug Manufacturers companies, Daito Pharmaceutical Co ranks better than 50.73% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Daito Pharmaceutical Co's Pre-Tax Income for the three months ended in Nov. 2025 was 円780 Mil. Daito Pharmaceutical Co's Revenue for the three months ended in Nov. 2025 was 円12,130 Mil. Therefore, Daito Pharmaceutical Co's pretax margin for the quarter that ended in Nov. 2025 was 6.43%.

The historical rank and industry rank for Daito Pharmaceutical Co's Pretax Margin % or its related term are showing as below:

TSE:4577' s Pretax Margin % Range Over the Past 10 Years
Min: 5.84   Med: 10.96   Max: 15.46
Current: 7.52


TSE:4577's Pretax Margin % is ranked better than
50.73% of 954 companies
in the Drug Manufacturers industry
Industry Median: 7.295 vs TSE:4577: 7.52

Daito Pharmaceutical Co  (TSE:4577) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Daito Pharmaceutical Co Pretax Margin % Related Terms


Daito Pharmaceutical Co Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co Pretax Margin % Chart

Daito Pharmaceutical Co Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.06 15.46 11.25 8.99 5.84

Daito Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.41 3.91 8.10 6.43 12.38

TSE:4577 vs ZTS, UTHR: Pretax Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Daito Pharmaceutical Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daito Pharmaceutical Co Pretax Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daito Pharmaceutical Co's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Daito Pharmaceutical Co's Pretax Margin % falls into.


TSE:4577
75GF Score
Daito Pharmaceutical Co Ltd TSE:4577
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daito Pharmaceutical Co Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Daito Pharmaceutical Co's Pretax Margin for the fiscal year that ended in May. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: May. 2025 )/Revenue (A: May. 2025 )
=2958/50643
=5.84 %

Daito Pharmaceutical Co's Pretax Margin for the quarter that ended in Nov. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Nov. 2025 )/Revenue (Q: Nov. 2025 )
=780/12130
=6.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of 6.43% mean?
Daito Pharmaceutical Co (TSE:4577) has a Pretax Margin % of 6.43% as of Nov. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Daito Pharmaceutical Co and its competitors. This is 41% below median its historical median of 10.96. Over the past decade, Daito Pharmaceutical Co's Pretax Margin % has ranged from 5.84 to 15.46. According to the industry distribution chart, Daito Pharmaceutical Co ranks #470 out of 954 companies in the Drug Manufacturers industry, placing it in the top 49.3%.
Is Daito Pharmaceutical Co's Pretax Margin % too high?
Daito Pharmaceutical Co's current Pretax Margin % of 6.43% is 41% below median its 10-year median of 10.96. Over the past 10 years, this metric has ranged from a low of 5.84 to a high of 15.46. The Drug Manufacturers industry median Pretax Margin % is 7.30. Daito Pharmaceutical Co's value of 6.43% is 11.9% below this industry median. Based on the distribution chart, Daito Pharmaceutical Co ranks #470 out of 954 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Daito Pharmaceutical Co has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Daito Pharmaceutical Co ranks #470 out of 954 companies for Pretax Margin %. This puts Daito Pharmaceutical Co in the upper half of its industry. The industry median Pretax Margin % is 7.30. Daito Pharmaceutical Co's value of 6.43% is 11.9% below this benchmark. Historically, Daito Pharmaceutical Co's own Pretax Margin % has ranged from 5.84 to 15.46 over the past decade. While the company's 10-year median is 10.96 vs. the industry median of 7.30, Daito Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daito Pharmaceutical Co's current Pretax Margin % of 6.43% is 11.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Daito Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daito Pharmaceutical Co's current Pretax Margin % is 6.43%, which is 41% below median its own 10-year median of 10.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,277.77, compared to a current price of 円1,241.00 — trading 2.9% below its estimated fair value. The current Pretax Margin % is 6.43%, which is 41% below median its 10-year median of 10.96 and 11.9% below the Drug Manufacturers industry median of 7.30. Daito Pharmaceutical Co's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current Pretax Margin % is 6.43% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued. The current stock price of 円1,241.00 is trading 2.9% below its estimated GF Value™ of 円1,277.77. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • Pretax Margin %: 6.43% (41% below median its 10-year median of 10.96)
  • GF Value™: 円1,277.77 vs. price of 円1,241.00 (2.9% below fair value)
  • GF Score™: 75/100 with 3 warning signs
  • Industry Position: 11.9% below the Drug Manufacturers median (#470 of 954)

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
75GF Score

Get the complete analysis for TSE:4577

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,241.00
Price
円1,277.77
GF Value